openPR Logo
Press release

Parenteral Drugs Market Shares, Growth, Size, Trends, Opportunities & Top Players by 2019 to 2029

02-03-2020 01:24 PM CET | Health & Medicine

Press release from: Fact.MR

Parenteral Drugs Market Shares, Growth, Size, Trends,

As the complexity of active pharmaceutical ingredients goes up, and includes small molecule options and biologics, the number of parenteral drugs has gone up as well. The number of new molecular products which have received the approval of regulatory bodies such as the FDA has gone up and has aided the growth of the industry for the foreseeable future. Major players in the parenteral drugs market are focusing their efforts on expanding their operations in terms of new countries to leverage opportunities in untapped markets, and also setting up new facilities for target markets. In a bid to secure a larger share of the market, manufacturers are also investing in the consolidation of extant production facilities.

Asia Pacific Being Targeted by Manufacturers

Major pharmaceutical companies from around the world are seeking the acquisition of smaller regional competitors, particularly those in the emerging markets of the Asia Pacific region, with the aim of maintaining sustainable rates of growth in terms of parenteral drugs. Further hospital pharmacies are gaining importance as primary channels of distribution owing to higher rates of hospitalization and the rising availability of requisitely skilled man power resources. Similar growth is also being projected for revenue being made by retail pharmacies.

Automation and Single Use Trends Support Rise

Single use strategies have been gaining traction in terms of proteins, antibodies, vaccines, cell therapy, and gene therapy processes. In addition, the FDA has been increasingly pushing for a higher rate of adoption of automation tech in the manufacturing of pharmaceuticals. On the other hand, adequately equipped automation technologies have not been developed for advanced products such as biologics, which is a key issue as manufacturers continue to raise the quality of their offerings.

You can Request an Example Copy from here - https://www.factmr.com/connectus/sample?flag=S&rep_id=3189

Single use technologies allows easier maintenance of quality standards for biologics parenteral drugs, even as the overall market value is projected to reach USD 802 billion by the end of the forecast period in 2029.

Large Molecule Drugs and Biologics are Key to Demand

Monoclonal antibodies are expected to generate major revenue share in the parenteral drugs market owing to the rising number of approvals by regulatory bodies in recent times. In addition, large molecule parenteral drugs are also expected to experience an upward trajectory, as they are finding use in treatment of ailments such as blood disease, cancer, and diabetes. The higher use of large molecule formulations are also going up owing to the biocompatible nature of these drugs.

Ask Industry Professional about Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=3189

However, the industry is restricted owing to the high capital requirements for research and lengthy approval times. The parenteral drug industry is also witnessing increased spending on research and development, with most of the focus centering on oncology, owing to the vast patient pool, which is providing substantial growth opportunities for new drug launches of biologics, which are largely developed in injectable forms.

Contact Us

FactMR
11140 Rockville Pike
Suite 400, Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Parenteral Drugs Market Shares, Growth, Size, Trends, Opportunities & Top Players by 2019 to 2029 here

News-ID: 1916841 • Views: 134

More Releases from Fact.MR

01-21-2021 | Health & Medicine
Fact.MR
Cardiac Ablation Technologies Market
Growing acceptance of catheter ablation as the first line of therapy, along with recent developments introducing robotic catheter navigation systems and 3D electro-anatomical mapping systems creates a highly conducive environment for the growth of the cardiac ablation technologies market. However, an extensive study published by Fact.MR raises concerns regarding technical complexity leading to lack of required operational competency, which leads to fundamental barriers to the adoption of advanced ablation systems. Request
01-21-2021 | Health & Medicine
Fact.MR
Carbapenem-based Antibiotics Market to Exhibit 7% CAGR, with Sales of Tebipenem …
Incidence of bacterial infections with multidrug resistance is increasing rapidly, generating the need for novel, broad-spectrum carbapenem-based antibiotics for the treatment of various bacterial infections. Broad-spectrum carbapenem-based antibiotics such as tebipenem (Spero Therapeutics Inc.) and sulopenem (Iterum Therapeutics Inc.) are at late stage clinical development with expected launch of both in 2020 - 2021. Multidrug resistance to currently marketed carbapenem-based antibiotics is largely prevalent in the world. Also, expiry of
01-21-2021 | Health & Medicine
Fact.MR
Asthma Treatment Market Projected to Witness a Double-Digit CAGR During 2020 to …
Retail pharmacies will drive the highest sales of asthma therapeutics with an estimated value of around US$ 17 Bn by 2027, as rapid expansion of retail pharmacies makes asthma therapeutics more accessible to patients. According to a recent Fact.MR study, hospital pharmacies with large drug inventories would also remain a crucial distribution channel in the asthma treatment market. As patients find it convenient to purchase drugs immediately after diagnosis, hospital
01-21-2021 | Health & Medicine
Fact.MR
Dental Consumables Market to Top US$ 50 Bn by 2030
Dental problems are becoming a cause for concern for people worldwide. This has led to manufacturers investing in research & development to come up with innovative products with changing times. Technological advancements leading to innovative products are expected to drive the global dental consumables market in the future. Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4420 For instance, due to problems created by the COVID 19 pandemic, companies are

All 5 Releases


More Releases for Drugs

Acne Drugs: Global Markets
The global market for acne drugs was valued at REDACTED in 2019. The market is expected to growat a compound annualgrowth rate (CAGR) of REDACTED to reach REDACTED by 2025. Growth of the global market is attributed the increasing numberof cases of acne and skin diseases, unhealthy eating habits and the rising adoption of skin care productsworldwide. To Get Sample Copy of Report Visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=2798596 Increasing prevalence of the acne and
Acne Drugs Market
According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025,”. Looking forward, IMARC Group expects the global acne drugs market to continue its moderate growth during the next five years. Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells